BiotechTubeBiotechTube
Home/Anteris Technologies/Dr. Andrew Holden, MBChB, FRANZCR, EBIR
DA

Dr. Andrew Holden, MBChB, FRANZCR, EBIR

Non-Executive Director

Anteris Technologies

Therapeutic Areas

CardiovascularStructural Heart Disease

Anteris Technologies Pipeline

DrugIndicationPhase
DurAVR™ THV SystemSevere Aortic Stenosis (Symptomatic)Early Feasibility Study

Leadership Team at Anteris Technologies

WP
Wayne Paterson, PhD
Chief Executive Officer & Managing Director
DC
Dr. Christopher Meduri, MD, MPH
Chief Medical Officer
FR
Felix Roosen
Chief Operating Officer
AM
Annie Miller
Chief Financial Officer
JW
John W. Cumming
Non-Executive Chairman
MA
Mark A. Meller
Non-Executive Director
View full Anteris Technologies profile